Smith, Salley & Associates Laboratory Corp Of America Holdings Transaction History

Smith, Salley & Associates

$1.5 Billion
Q4 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$197.69 - $227.29 $16,210 - $18,637	-82 Reduced 5.53%	1,401 $318,000
Q3 2023 Oct 27, 2023	SELL	$201.05 - $221.7 $152,194 - $167,826	-757 Reduced 33.79%	1,483 $298,000
Q2 2023 Aug 04, 2023	SELL	$211.93 - $241.33 $12 Million - $13.7 Million	-56,742 Reduced 96.2%	2,240 $540,000
Q1 2023 May 03, 2023	BUY	$213.32 - $257.83 $315,073 - $380,814	1,477 Added 2.57%	58,982 $13.5 Million
Q4 2022 Feb 03, 2023	SELL	$203.72 - $248.97 $25,261 - $30,872	-124 Reduced 0.22%	57,505 $13.5 Million
Q3 2022 Nov 01, 2022	BUY	$204.81 - $262.19 $76,598 - $98,059	374 Added 0.65%	57,629 $11.8 Million
Q2 2022 Aug 01, 2022	BUY	$213.86 - $277.87 $534,863 - $694,952	2,501 Added 4.57%	57,255 $13.4 Million
Q1 2022 May 10, 2022	BUY	$259.82 - $298.18 $194,605 - $223,336	749 Added 1.39%	54,754 $14.4 Million
Q4 2021 Feb 10, 2022	BUY	$271.6 - $314.21 $188,490 - $218,061	694 Added 1.3%	54,005 $17 Million
Q3 2021 Nov 05, 2021	BUY	$274.82 - $308.34 $9,069 - $10,175	33 Added 0.06%	53,311 $15 Million
Q2 2021 Aug 09, 2021	BUY	$251.87 - $278.14 $43,321 - $47,840	172 Added 0.32%	53,278 $14.7 Million
Q1 2021 Apr 30, 2021	SELL	$204.88 - $255.03 $3.37 Million - $4.19 Million	-16,443 Reduced 23.64%	53,106 $13.5 Million
Q4 2020 Jan 28, 2021	BUY	$186.91 - $214.42 $466,527 - $535,192	2,496 Added 3.72%	69,549 $14.2 Million
Q3 2020 Nov 05, 2020	BUY	$167.03 - $201.3 $76,499 - $92,195	458 Added 0.69%	67,053 $12.6 Million
Q2 2020 Aug 04, 2020	BUY	$113.31 - $182.44 $268,431 - $432,200	2,369 Added 3.69%	66,595 $11.1 Million
Q1 2020 Apr 24, 2020	BUY	$104.32 - $195.28 $130,504 - $244,295	1,251 Added 1.99%	64,226 $8.12 Million
Q4 2019 Jan 27, 2020	SELL	$163.48 - $173.61 $23,868 - $25,347	-146 Reduced 0.23%	62,975 $10.7 Million
Q3 2019 Oct 30, 2019	BUY	$159.77 - $178.1 $357,884 - $398,944	2,240 Added 3.68%	63,121 $10.6 Million
Q2 2019 Jul 12, 2019	BUY	$144.16 - $172.9 $335,316 - $402,165	2,326 Added 3.97%	60,881 $10.5 Million
Q1 2019 May 03, 2019	BUY	$123.7 - $156.3 $1.41 Million - $1.78 Million	11,385 Added 24.14%	58,555 $8.96 Million
Q4 2018 Feb 05, 2019	BUY	$120.82 - $174.09 $6,524 - $9,400	54 Added 0.11%	47,170 $5.96 Million
Q3 2018 Nov 06, 2018	BUY	$167.67 - $188.27 $159,454 - $179,044	951 Added 2.06%	47,116 $8.18 Million
Q2 2018 Aug 10, 2018	BUY	$160.33 - $189.41 $213,238 - $251,915	1,330 Added 2.97%	46,165 $8.29 Million
Q1 2018 May 09, 2018	BUY	$161.53 - $178.11 $69,296 - $76,409	429 Added 0.97%	44,835 $7.25 Million
Q4 2017 Feb 12, 2018	BUY	$147.99 - $163.95 $138,518 - $153,457	936 Added 2.15%	44,406 $7.08 Million
Q3 2017 Nov 02, 2017	BUY	$149.47 - $160.56 $6.5 Million - $6.98 Million	43,470	43,470 $6.56 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.

Account